Aventis Files Additional Suits Over Allegra Patents
The lawsuits were filed in the U.S. District Court of New Jersey and are based on United States Patent Nos. 5,581,011 and 5,750,703, which are owned by AMR Technology, Inc. and exclusively licensed to Aventis.
These patents, which expire in the late 2013-2015 timeframe, claim fexofenadine intermediates and processes for making fexofenadine.
The French company said it...
To view the full article, register now.